课题基金 / 基金详情

STUDY OF PLATINUM COMPOUND AND PACLITAXEL IN EPITHELIAL OVARIAN CARCINOMA

STUDY OF PLATINUM COMPOUND AND PACLITAXEL IN EPITHELIAL OVARIAN CARCINOMA
铂化合物与紫杉醇治疗上皮性卵巢癌的研究
批准号：
5221731
负责人：
JONATHAN S BEREK
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5221731
关键词：
antineoplastics cis platinum compound clinical research combination chemotherapy drug adverse effect drug screening /evaluation female human subject human therapy evaluation neoplasm /cancer chemotherapy neoplasm /cancer classification /staging neoplasm /cancer relapse /recurrence ovary neoplasms

项目摘要

项目成果

JONATHAN S BEREK的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The specific aims of this study are to compare recurrence-free interval and survival in patients with optimal (<1 cm residual) stage III epithelial ovarian cancer treated with two different treatment regimens of cisplatin/carboplatin and paclitaxel; compare toxicity and complications of two different regimens for administering cisplatin/carboplatin and paclitaxel in patients with optimal (<1 cm residual) stage III epithelial ovarian cancer; and correlate serial measurements of serum CA-125 levels with recurrence-free interval.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF PLATINUM COMPOUND AND PACLITAXEL IN EPITHELIAL OVARIAN CARCINOMA
STUDY OF PLATINUM COMPOUND AND PACLITAXEL IN EPITHELIAL OVARIAN CARCINOMA
RANDOMIZED PHASE III TRIAL OF CARBOPLATIN (AUC 7.5) AND PACLITAXEL
RANDOMIZED PHASE III TRIAL OF CARBOPLATIN (AUC 7.5) AND PACLITAXEL